icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections (CROI)
February 22-25, 2016, Boston MA
Back grey_arrow_rt.gif
 
 
 
A Long-Acting Biodegradable Subcutaneous Implant for
Tenofovir Alafenamide Fumarate HIV PrEP
 
 
  CROI 2016
Reported by Jules Levin
 
Erica Schlesinger1, Daniel Johengen1, Leah Johnson3, Stephanie Swarner3, Ginger Rothrock3 , Ian McGowan4, Ariane van der Straten2, Tejal Desai1
1. Joint Graduate Group in Bioengineering, University of California Berkeley – University of California San Francisco
2. Women’s Global Health Imperative, RTI International, San Francisco; 3. RTI International, RTP; 4. Magee Women’s Research Institute and Foundation/University of Pittsburgh
 
Pharmacokinetics of Long-acting Tenofovir Alafenamide (GS-7340) Subdermal Implant for HIV Prophylaxis http://www.natap.org/2016/HIV/021116_01.htm

1save

0131172

0131173

0131174

0131175

0131176